Sharing records and encouraging conversation will promote better collaboration between primary care and cancer care, said Jeffrey Lowenkron, MD, chief medical officer of The Villages Health.
Sharing records and encouraging conversation will promote better collaboration between primary care and cancer care, said Jeffrey Lowenkron, MD, chief medical officer of The Villages Health.
Transcript:
What are some best practices for promoting better collaboration between primary care and cancer care?
Probably the best thing we can do is share records and have conversations with each other. We have a good collaborative, conversational relationship with Florida cancer specialists, which is really the only group that's really delivering cancer care up in The Villages. Our folks really do a nice job of communicating with them and they do a nice job of communicating back.
What are the biggest barriers to good care coordination among Medicare beneficiaries?
I'd say probably the understanding of what really good options are for them, and the idea that many times they'll think their neighbors will have a better suggestion for what their care plan should be, than their physicians. Up in The Villages, everybody knows everybody else and they have a strong network where they all talk to each other. It's helpful in many instances and potentially challenging in others. The overall difficulty for care coordination across the board, is that people are often on separate records. And they're not necessarily all working from the same care plan. That difficulty may put patients in the middle of what's going on instead of having them be the center of all the care.
Sequencing CAR T and Bispecifics for Multiple Myeloma: Tyler Sandahl, PharmD
July 8th 2025Tyler Sandahl, PharmD, a clinical pharmacist at Mayo Clinic, explains that sequencing novel multiple myeloma therapies with CAR T-cell therapy is generally prioritized first for eligible patients, while bispecific antibodies are reserved for later lines or for patients unable to tolerate CAR T.
Read More
Insurance Gaps Threaten Cancer Treatment Success
July 7th 2025Access to and affordability of immune checkpoint inhibitors, which can be lifesaving if patients receive them on time and under optimal circumstances, continue to top the list of reasons behind outcomes disparities for patients who have private insurance vs those who remain uninsured.
Read More